MARKET INTELLIGENCE REPORT
Ashley Chacko
Senior Vice President, Market Intelligence and Strategic Planning at Healthcare Outcomes Performance Company (HOPCo)
Modern Healthcare 1/9/2025
·??Health systems divested hospitals at a record pace last year, a new report shows.
·???Nearly two-thirds of the 72 announced?hospital transactions?in 2024 involved an organization that was?selling facilities, according to the latest data from Kaufman Hall. That’s?double the percentage in 2023?and the highest tally tracked by the consultancy
?
The Wall Street Journal 1/17/2025
·?? The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including?Ozempic?and?Wegovy, the drugs at the center of the weight-loss craze.
·???The Biden administration said the drugs account for $41 billion in annual Medicare spending, and that price negotiations could result in significant savings. U.S. health officials selected the drugs because they account for high Medicare spending due to widespread use or high price tags.
?
Beckers 1/13/2025
·???While ASCs remain largely independent, consolidation is on the rise in the industry, influenced by various factors such as compensation and reimbursement issues, inflation and operational changes, and a possible shift toward independence among employed physicians.
?
Modern Healthcare 1/22/2025
·???President Donald Trump has rescinded a set of insurance, drug pricing and public health executive orders that laid the groundwork for former President Joe Biden’s major healthcare policy priorities, and started establishing his own agenda.
·???Trump was prolific with executive orders in his first term and kicked off his second term with similar vigor. In all, Trump nixed 78 of Biden's executive orders Monday, and issued a handful of his own executive orders on global health and nondiscrimination compliance.